Cytokinetics opens applications for $20,000 grants to nonprofits supporting health equity and science education.

Cytokinetics, a cardiovascular biopharmaceutical company, announced its annual Corporate Giving Program inviting U.S. nonprofits to apply for donations up to $20,000. The program supports organizations focused on equitable healthcare for cardiovascular disease, science education, and essential services for local and at-risk communities in the San Francisco Bay Area and Greater Philadelphia Region. Applications are open until August 3, 2026. This initiative reflects Cytokinetics' commitment to community health and opportunity alongside its scientific mission.